Hormone therapy linked to ovarian cancer risk
(Reuters


Reuters - The risk of ovarian cancer is
increased in women who use unopposed estrogen for 10 years or
more, and in those taking estrogen and progestin for 5 years or
more, according to a report in The Journal of the National
Cancer Institute.